Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Cited by (1,000)

Items 301–400 of 1,000

1. Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies
   Muhammad Umer, Ramanathan Vaidyanathan, Nam‐Trung Nguyen, Muhammad J. A. Shiddiky · 2018 · Biotechnology Advances
2. PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer
   Bo Liu, Likun Li, Guang Yang, Chuandong Geng, Yong Luo, Wenhui Wu, Ganiraju C. Manyam, Dimitrios K. Korentzelos, Sanghee Park, Zhe Tang et al. · 2019 · Clinical Cancer Research
3. 3D modeling in cancer studies
   Oula El Atat, Zahra Farzaneh, Mahsa Pourhamzeh, Fatima Taki, Ralph Joseph Abi‐Habib, Massoud Vosough, Mirvat El‐Sibai · 2021 · Human Cell
4. Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
   Zujun Que, Bin Luo, Zhiyi Zhou, Changsheng Dong, Yi Jiang, Lin Wang, Qihui Shi, Jianhui Tian · 2019 · Cancer Cell International
5. Druggable genome and precision medicine in cancer: current challenges
   Camille Dupont, Kristina Riegel, Malvika Pompaiah, Hartmut H. Juhl, Krishnaraj Rajalingam · 2021 · FEBS Journal
6. Phase separation of EML4–ALK in firing downstream signaling and promoting lung tumorigenesis
   Zhen Qin, Honghua Sun, Meiting Yue, Xinwen Pan, Liang Chen, Xin‐Hua Feng, Xiumin Yan, Xueliang Zhu, Hongbin Ji · 2021 · Cell Discovery
7. Enabling peristalsis of human colon tumor organoids on microfluidic chips
   Fang, Guocheng, Lu, Hongxu, Al-Nakashli, Russul, Chapman, Robert, Zhang, Yingqi, Ju, Lining Arnold, Lin, Gungun, Stenzel, Martina H, Jin, Dayong · 2022 · Biofabrication
8. A microfluidic platform for functional testing of cancer drugs on intact tumor slices
   Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C. et al. · 2020 · Lab on a Chip
9. Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids
   Zachary A. Richards, Tara McCray, Joseph Marsili, Morgan L. Zenner, Jacob T. Manlucu, Jason V. Garcia, Andre Kajdacsy‐Balla, Marcus Murray, Cindy Voisine, Adam Bryant Murphy et al. · 2019 · iScience
10. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
    Nobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa, Gen Hiyama, Hirosumi Tamura, Mayu Ogawa, Kosuke Takagi, Kazuhito Goda, Naoyuki Okabe, Satoshi Muto et al. · 2019 · Cells
11. Mathematical Models of Organoid Cultures
    Sandra Montes-Olivas, Lucia Marucci, Martin Homer · 2019 · Frontiers in Genetics
12. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
    Sahithi Pamarthy, Hatem E. Sabaawy · 2021 · Molecular Cancer
13. Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy
    Shihong Peng, Pan Hu, Yu-Tian Xiao, Weiqiang Lü, Dandan Guo, Shixiu Hu, Jiayi Xie, Minna Wang, Weiwei Yu, Junjie Yang et al. · 2021 · Clinical Cancer Research
14. Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
    Zahra Eslami‐S, Luis Enrique Cortés‐Hernández, Frédéric Thomas A, Klaus Pantel, Catherine Alix‐Panabières · 2022 · British Journal of Cancer
15. Prostate Stem Cells and Cancer Stem Cells
    Jia J. Li, Michael M. Shen · 2018 · Cold Spring Harbor Perspectives in Medicine
16. Addressing Patient Specificity in the Engineering of Tumor Models
    Laura Jane Bray, Dietmar Werner Hutmacher, Nathalie Bock · 2019 · Frontiers in Bioengineering and Biotechnology
17. Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients
    Jing‐Hua Chen, Xiangpeng Chu, Jia‐Tao Zhang, Qiang Nie, Wen‐Fang Tang, Jian Su, Hong‐Hong Yan, Hongping Zheng, Ze‐Xin Chen, Xin Chen et al. · 2020 · Thoracic Cancer
18. Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer
    Su H. Park, Ka-wing Fong, Jung Kim, Fang Wang, Xiaodong Lü, Yongik Lee, Lourdes T. Brea, Kristine M. Wadosky, Chunming Guo, Sarki Abba Abdulkadir et al. · 2021 · Science Advances
19. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
    Gail Petuna Risbridger, Ashlee K. Clark, Laura H. Porter, Roxanne Toivanen, Andrew Bakshi, Natalie L. Lister, David William Pook, Carmel Jo Pezaro, Shahneen Kaur Sandhu, Shivakumar Keerthikumar et al. · 2021 · Nature Communications
20. Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis
    Hyun Ho Han, Yan Wang, Josué Curto, Sreeharsha Gurrapu, Sara Laudato, Alekya Rumandla, Goutam Chakraborty, Xiaobo Wang, Hong Chen, Yan Jiang et al. · 2022 · Cell Reports
21. Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies
    Zhenzhen Zhou, Yuan Pang, Jingyuan Ji, Jianyu He, Tiankun Liu, Liliang Ouyang, Wen Zhang, Xueli Zhang, Zhigang Zhang, Kaitai Zhang et al. · 2023 · Nature reviews. Immunology
22. Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement
    Molly M. Morgan, Brian P. Johnson, Megan K. Livingston, Linda A. Schuler, Elaine T. Alarid, Kyung Eun Sung, David J. Beebe · 2016 · Pharmacology & Therapeutics
23. Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future
    Mahesh Devarasetty, Andrea R. Mazzocchi, Aleksander Skardal · 2018 · BioDrugs
24. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer
    Su, Yang, Liu, Yue, Behrens, Christopher R., Bidlingmaier, Scott, Lee, Nam-Kyung, Aggarwal, Rahul, Sherbenou, Daniel W., Burlingame, Alma L., Hann, Byron C., Simko, Jeffry P. et al. · 2018 · JCI Insight
25. Organoid technology for tissue engineering
    Juan He, Xiaoyu Zhang, Xinyi Xia, Ming Han, Fei Li, Chunfeng Li, Yunguang Li, Dong Gao · 2020 · Journal of Molecular Cell Biology
26. Drug screening model meets cancer organoid technology
    Chen Liu, Tianyu Qin, Yuhan Huang, Yuan Li, Gang Chen, Chaoyang Sun · 2020 · Translational Oncology
27. Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
    Henry Jeison Ruiz-Garcia, Keila Alvarado-Estrada, Paula V. Schiapparelli, Alfredo Quiñones‐Hinojosa, Daniel Michael Trifiletti · 2020 · Frontiers in Cellular Neuroscience
28. From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research
    Gat Rauner, Piyush B. Gupta, Charlotte Kuperwasser · 2025 · Nature Methods
29. Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
    Gail Petuna Risbridger, Roxanne Toivanen, Renea A. Taylor · 2018 · Cold Spring Harbor Perspectives in Medicine
30. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer
    Dong Chen, Yawen Tan, Zhichao Li, Wujiao Li, Lei Yu, Wei Chen, Yuchen Liu, Lisa Liu, Liangfeng Guo, Weiren Huang et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
31. Organoid technology in cancer precision medicine
    Xinyi Xia, Fei Li, Juan He, Rebiguli Aji, Dong Gao · 2019 · Cancer Letters
32. Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications
    Qian Zhang, Yuan Rong, Kezhen Yi, Lanxiang Huang, Ming Chen, Xinghuan Wang · 2020 · Theranostics
33. SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase
    Hengrui Zhu, Shancheng Ren, Benjamin Guy Bitler, Katherine M. Aird, Zhigang Tu, Emmanuel Skordalakes, Yasheng Zhu, Jun Yan, Yinghao Sun, Rugang Zhang · 2015 · Cell Reports
34. 3D Culture as a Clinically Relevant Model for Personalized Medicine
    Eliza Li Shan Fong, Tan Boon Toh, Hanry Yu, Edward Kai‐Hua Chow · 2017 · SLAS TECHNOLOGY
35. A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma
    Duangporn Saengwimol, Duangnate Rojanaporn, Vijender Chaitankar, Pamorn Chittavanich, Rangsima Aroonroch, Tatpong Boontawon, Weerin Thammachote, Natini Jinawath, Suradej Hongeng, Rossukon Kaewkhaw · 2018 · Scientific Reports
36. Towards manufacturing of human organoids
    Aswathi Ashok, Deepak Choudhury, Yu Fang, Walter Hunziker · 2019 · Biotechnology Advances
37. Rapid Label-Free Isolation of Circulating Tumor Cells from Patients’ Peripheral Blood Using Electrically Charged Fe 3 O 4 Nanoparticles
    Sheng‐Ming Wu, Lei Gu, Jingwen Qin, Lei Zhang, Fenyong Sun, Zhongchen Liu, Yilong Wang, Donglu Shi · 2020 · ACS Applied Materials & Interfaces
38. Model organoids provide new research opportunities for ductal pancreatic cancer
    Sylvia F. Boj, Chang‐Il Hwang, Lindsey A. Baker, Dannielle D. Engle, David A. Tuveson, Hans C. Clevers · 2015 · Molecular & Cellular Oncology
39. Functional studies on circulating and disseminated tumor cells in carcinoma patients
    Catherine Alix‐Panabières, Kai Bartkowiak, Klaus Pantel · 2016 · Molecular Oncology
40. ATG5 cancer mutations and alternative mRNA splicing reveal a conjugation switch that regulates ATG12–ATG5-ATG16L1 complex assembly and autophagy
    Daric J. Wible, Hsueh‐Ping Chao, Dean G. Tang, Shawn B. Bratton · 2019 · Cell Discovery
41. Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
    Kenji Unno, Zachary Rockow Chalmers, Sahithi Pamarthy, Rajita J. Vatapalli, Yara Rodríguez, Barbara Lysy, Hanlin Mok, Vinay Sagar, Huiying Han, Young A. Yoo et al. · 2021 · Cancer Research
42. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons
    Carlyn Rose C. Tan, Lanlan Zhou, Wafik S. El‐Deiry · 2016 · Current Colorectal Cancer Reports
43. Difference Makers: Chromosomal Instability versus Aneuploidy in Cancer
    Richard H. van Jaarsveld, Geert J.P.L. Kops · 2016 · Trends in cancer
44. Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway
    Kiran Kurmi, Sadae Hitosugi, Jia Yu, Felix Boakye‐Agyeman, Elizabeth K. Wiese, Thomas R. Larson, Qing Dai, Yuichi Machida, Zhenkun Lou, Liewei Wang et al. · 2018 · Cell Metabolism
45. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
    Miriam Hegemann, Arnulf Stenzl, Jens Bedke, Kim N. Chi, Peter C. Black, Tilman Todenhöfer · 2016 · British Journal of Urology
46. Organoid Technology: Current Standing and Future Perspectives
    Laleh Shariati, Yasaman Esmaeili, Shaghayegh Haghjooy Javanmard, Elham Bidram, Abbas Amini · 2021 · Stem Cells
47. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids
    Nicholas Choo, Susanne Ramm, Jennii Luu, Jean M. Winter, Luke A. Selth, Amy R. Dwyer, Mark Frydenberg, Jeremy Grummet, Shahneen Kaur Sandhu, Theresa E. Hickey et al. · 2021 · SLAS DISCOVERY
48. Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer
    Chaping Cheng, Jinming Wang, Penghui Xu, Kai Zhang, Zhixiang Xin, Huifang Zhao, Zhongzhong Ji, Man Zhang, Deng Wang, Yuman He et al. · 2022 · Nature Cancer
49. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
    Ergang Wang, Kun Xiang, Yun Zhang, Xiao‐Fan Wang · 2022 · Journal of the National Cancer Center
50. Genetic engineering in organoids
    Teriyapirom, Isaree, Batista-Rocha, Andreia S., Koo, Bon-Kyoung · 2021 · Journal of Molecular Medicine
51. Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry
    Amanda Khoo, Lydia Liu, Julius O. Nyalwidhe, O. John Semmes, Danny Vesprini, Michelle R. Downes, Paul Christopher Boutros, Stanley K. Liu, Thomas Kislinger · 2021 · Nature Reviews Urology
52. Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
    Xiaoxue Ren, Weikang Chen, Qingxia Yang, Xiaoxing Li, Lixia Xu · 2022 · Journal of Gastroenterology and Hepatology
53. Experimental in vitro, ex vivo and in vivo models in prostate cancer research
    Verena Sailer, Gunhild v. Amsberg, Stefan M. Duensing, Jutta Kirfel, Verena Lieb, Eric Metzger, Anne Offermann, Klaus Pantel, Roland Schüle, Helge W. Taubert et al. · 2022 · Nature Reviews Urology
54. Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma
    David Roife, Bingbing Dai, Ya’an Kang, Mayrim V. Rios Perez, Michael F. Pratt, Xinqun Li, Jason B. Fleming · 2016 · Clinical Cancer Research
55. Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
    Nuzhat Ahmed, Elif Kadife, Ali Raza, Mary K. Short, Paul T. Jubinsky, George Kannourakis · 2020 · Cells
56. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
    Maxim E. Menyailo, Maria S. Tretyakova, Evgeny V. Denisov · 2020 · International Journal of Molecular Sciences
57. Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancers
    Zhixin Qiu, Keke Zou, Liping Zhuang, Jianjie Qin, Hong Li, Chao Li, Zhengtao Zhang, Xiaotao Chen, Jin Cen, Zhiqiang Meng et al. · 2016 · Scientific Reports
58. Circulating Tumor Cells
    Ashutosh Agarwal, Marija Balić, Dorraya El‐Ashry, Richard J. Côté · 2018 · The Cancer Journal
59. Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
    Marta Tellez-Gabriel, Denis Cochonneau, Marie Cadé, Camille Jubelin, Marie‐Françoise Heymann, Dominique Heymann · 2018 · Cancers
60. Drug Discovery via Human-Derived Stem Cell Organoids
    Fangkun Liu, Jing Huang, Bo Ning, Zhixiong Liu, Shen Chen, Wei Zhao · 2016 · Frontiers in Pharmacology
61. Organoid technology in female reproductive biomedicine
    Heidar Heidari Khoei, Fereshteh Esfandiari, Mohammad Amin Hajari, Zeynab Ghorbaninejad, Abbas Piryaei, Hossein Baharvand · 2020 · Reproductive Biology and Endocrinology
62. Patient-Derived Organoids as a Model for Cancer Drug Discovery
    Colin J. Rae, Francesco Amato, Chiara Braconi · 2021 · International Journal of Molecular Sciences
63. Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imaging
    Anurup Ganguli, Ariana Mostafa, C. Saavedra, Yongdeok Kim, Phuong Le, Vahid Faramarzi, Ryan W. Feathers, Jacob Berger, Karla P. Ramos-Cruz, Olaoluwa O. Adeniba et al. · 2021 · Science Advances
64. Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
    S.Y. Jeong, Minyong Kang · 2023 · International Journal of Molecular Sciences
65. Organoid development in cancer genome discovery
    Dong Gao, Yu Chen · 2015 · Current Opinion in Genetics & Development
66. Cell types of origin for prostate cancer
    Suk Hyung Lee, Michael M. Shen · 2015 · Current Opinion in Cell Biology
67. Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53- deficiency-driven castration-resistant prostate cancer
    Lei Wang, Ji Wang, Hua Xiong, Fengxia Wu, Tian Lan, Yingjie Zhang, Xiaolan Guo, Huanan Wang, Mohammad Saleem, Cheng Jiang et al. · 2016 · EBioMedicine
68. Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine
    Kelly A. Whelan, Amanda B. Muir, Hiroshi Nakagawa · 2018 · Cellular and Molecular Gastroenterology and Hepatology
69. Deregulation of SPOP in Cancer
    Hui Zhang, Xiaofeng Jin, Haojie Huang · 2022 · Cancer Research
70. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer
    Timofeeva, Olga A., Palechor-Ceron, Nancy, Li, Guanglei, Yuan, Hang, Krawczyk, Ewa, Zhong, Xiaogang, Liu, Geng, Upadhyay, Geeta, Dakic, Aleksandra, Yu, Songtao et al. · 2017 · Oncotarget
71. Dissecting cell-type-specific roles of androgen receptor in prostate homeostasis and regeneration through lineage tracing
    Qing Mei Xie, Yueli Liu, Tao Cai, Corrigan Horton, Joshua Stefanson, Zhu A. Wang · 2017 · Nature Communications
72. The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
    Arutha Kulasinghe, Hanjie Wu, Chamindie Punyadeera, Majid Ebrahimi Warkiani · 2018 · Micromachines
73. Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
    Sirin Saranyutanon, Sachin Kumar Deshmukh, Santanu Dasgupta, Sachin Gopalkrishna Pai, Seema Singh, Ajay P. Singh · 2020 · Cancers
74. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Fiona Helen Blackhall, Kristopher K. Frese, Kathryn Simpson, Elaine Kilgour, Gerard Brady, Caroline Dive · 2018 · The Lancet Oncology
75. Organoid Models for Cancer Research
    Hans C. Clevers, David A. Tuveson · 2019 · Annual Review of Cancer Biology
76. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis
    Parthasarathy Seshacharyulu, Satyanarayana Rachagani, Sakthivel Muniyan, Jawed Akhtar Siddiqui, Eric Cruz, Sunandini Sharma, Ramakrishnan Krishnan, Brigham J. Killips, Yuri M. Sheinin, Subodh M. Lele et al. · 2019 · Oncogene
77. Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
    Tara L. Hogenson, Hao Xie, William J. Phillips, Merih Deniz Toruner, Jing Li, Isaac P. Horn, Devin J. Kennedy, Luciana L. Almada, David L. Marks, Ryan Michael Carr et al. · 2022 · JCI Insight
78. Reprogramming of human cancer cells to pluripotency for models of cancer progression
    Jungsun Kim, Kenneth S. Zaret · 2015 · The EMBO Journal
79. Dawn of the organoid era
    Ninouk Akkerman, Libert H.K. Defize · 2017 · BioEssays
80. Recent advances in cancer metabolism: a technological perspective
    Yun Pyo Kang, Nathan P. Ward, Gina M. DeNicola · 2018 · Experimental & Molecular Medicine
81. Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
    Ryan C. Smith, Viviane S. Tabar · 2018 · Cell stem cell
82. Novel approaches in cancer management with circulating tumor cell clusters
    Peyman Rostami, Navid Kashaninejad, Khashayar Moshksayan, Mohammad Said Saidi, Bahar Firoozabadi, Nam‐Trung Nguyen · 2019 · Journal of Science Advanced Materials and Devices
83. Microdissected “cuboids” for microfluidic drug testing of intact tissues
    Horowitz, Lisa F., Rodriguez, Adan D., Au-Yeung, Allan, Bishop, Kevin W., Barner, Lindsey A., Mishra, Gargi, Raman, Aashik, Delgado, Priscilla, Liu, Jonathan T. C., Gujral, Taranjit S. et al. · 2021 · Lab on a Chip
84. Defining the Teratoma as a Model for Multi-lineage Human Development
    Daniella McDonald, Yan Wu, Amir Dailamy, Justin Tat, Udit Parekh, Dongxin Zhao, Michael Y. Hu, Ann M. Ponsford Tipps, Kun Zhang, Prashant Mali · 2020 · Cell
85. Organoid models of the tumor microenvironment and their applications
    Tao Xia, Wen‐Lin Du, Xiaoyi Chen, You-Ni Zhang · 2021 · Journal of Cellular and Molecular Medicine
86. Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy
    Lichan Chen, Xiafei Wei, Dayong Gu, Yong Xu, Hongzhong Zhou · 2023 · Cancer Letters
87. Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
    David R. Wise, Jeffrey A. Schneider, Joshua Armenia, Victor Adorno Febles, Bridget E. McLaughlin, Ryan Brennan, Katie L. Thoren, Wassim M. Abida, Karen Sandell Sfanos, Angelo Michael De Marzo et al. · 2020 · JCO Precision Oncology
88. Liquid biopsy in pancreatic cancer: the beginning of a new era
    Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang · 2018 · Oncotarget
89. The frontier of live tissue imaging across space and time
    Qiang Huang, Aliesha Garrett, Shree Bose, Stephanie J. Blocker, Anne C. Rios, Hans C. Clevers, Xiling Shen · 2021 · Cell stem cell
90. Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities
    Yu-Ping Yang, Teresa M. Giret, Richard J. Côté · 2021 · Cancers
91. Imaging-Based Machine Learning Analysis of Patient-Derived Tumor Organoid Drug Response
    Erin R. Spiller, Nolan M. Ung, Seungil Kim, Katherin Patsch, Roy Lau, Carly Strelez, Chirag Doshi, Sarah Choung, Brandon Choi, Edwin F. Juarez et al. · 2021 · Frontiers in Oncology
92. The role of organoids in cancer research
    Zhen Fang, Peijuan Li, Fengying Du, Liang Shang, Leping Li · 2023 · Experimental Hematology and Oncology
93. Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay
    Catherine Alix‐Panabières, Klaus Pantel · 2015 · Expert Review of Molecular Diagnostics
94. Short term ex-vivo expansion of circulating head and neck tumour cells
    Arutha Kulasinghe, Chris Perry, Majid Ebrahimi Warkiani, Tony Blick, Anthony Mitchell Davies, Kenneth John O'Byrne, Erik W. Thompson, Colleen C. Nelson, Ian Vela, Chamindie Punyadeera · 2016 · Oncotarget
95. Development of a functional thyroid model based on an organoid culture system
    Yoshiyuki Saito, Nobuyuki Onishi, Hiroshi E. Takami, Ryo Seishima, Hiroyoshi Inoue, Yuki Hirata, Kaori Kameyama, Kenji Tsuchihashi, Eiji Sugihara, Shinya Uchino et al. · 2018 · Biochemical and Biophysical Research Communications
96. Tumor organoids: From inception to future in cancer research
    Liang Yang, Shuo Yang, Xinyu Li, Bowen Li, Yan Li, Xiaodong Zhang, Yingbo Ma, Xueqiang Peng, Hongyuan Jin, Qing Fan et al. · 2019 · Cancer Letters
97. Current status of liquid biopsies for the detection and management of prostate cancer
    Yi‐Tsung Lu, Kevin Delijani, Andrew Mecum, Amir Goldkorn · 2019 · Cancer Management and Research
98. Patient-derived organoids of non-small cells lung cancer and their application for drug screening
    Yunfeng Li, Yanyun Gao, Baoran Liang, Xixi Cao, Zhangchi Sun, Justin HY. Yu, Z. D. Liu, Yong Han · 2020 · Neoplasma
99. A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
    James A. Saltsman, William J. Hammond, Nicole J.C. Narayan, David Requena, Helmuth Gehart, Gadi Lalazar, Michael P. LaQuaglia, Hans C. Clevers, Sanford M. Simon · 2020 · Cancers
100. Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
     Yasutaka Yamada, Varadha Balaji Venkadakrishnan, Kei Mizuno, Martin K. Bakht, Sheng‐Yu Ku, Maria Mica Garcia, Himisha Beltran · 2023 · Science Translational Medicine